Platelets do not express the oxidized or reduced forms of tissue factor |
| |
Authors: | Beth A. Bouchard Matthew T. GisselMatthew F. Whelihan Kenneth G. MannSaulius Butenas |
| |
Affiliation: | Department of Biochemistry, University of Vermont College of Medicine, Burlington, VT, USA |
| |
Abstract: |
BackgroundExpression of tissue factor (TF) antigen and activity in platelets is controversial and dependent upon the laboratory and reagents used. Two forms of TF were described: an oxidized functional form and a reduced nonfunctional form that is converted to the active form through the formation of an allosteric disulfide. This study tests the hypothesis that the discrepancies regarding platelet TF expression are due to differential expression of the two forms.MethodsSpecific reagents that recognize both oxidized and reduced TF were used in flow cytometry of unactivated and activated platelets and western blotting of whole platelet lysates. TF-dependent activity measurements were used to confirm the results.ResultsWestern blotting analyses of placental TF demonstrated that, in contrast to anti-TF#5, which is directed against the oxidized form of TF, a sheep anti-human TF polyclonal antibody recognizes both the reduced and oxidized forms. Flow cytometric analyses demonstrated that the sheep antibody did not react with the surface of unactivated platelets or platelets activated with thrombin receptor agonist peptide, PAR-1. This observation was confirmed using biotinylated active site-blocked factor (F)VIIa: no binding was observed. Likewise, neither form of TF was detected by western blotting of whole platelet lysates with sheep anti-hTF. Consistent with these observations, no FXa or FIXa generation by FVIIa was detected at the surface of these platelets. Similarly, no TF-related activity was observed in whole blood using thromboelastography.Conclusion and significancePlatelets from healthy donors do not express either oxidized (functional) or reduced (nonfunctional) forms of TF. |
| |
Keywords: | TF, tissue factor F, factor CTI, corn trypsin inhibitor hTF, human TF PE, phycoerythrin FPRck, D-Phe-Pro-Arg-CH2Cl rFVIIa, recombinant FVIIa PAR, protease activated receptor LPS, lipopolysaccharide RGDS, Arg-Gly-Asp-Ser HRP, horseradish peroxidase PCPS, 80% phosphatidylcholine/20% phosphatidylserine containing vesicles TEG, thromboelastography PRP, platelet-rich plasma TAT, thrombin-antithrombin SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis 5 × SPB, 312.5 mM Tris, pH 6.8, 10% sodium dodecyl sulfate, 50% glycerol, 0.05% bromophenol blue Mrapp, apparent molecular weight kDa, kilodalton |
本文献已被 ScienceDirect 等数据库收录! |
|